Mr. Ackerman, a partner in our Los Angeles office, advises clients on complex FDA issues that require coordinated legal, regulatory, and public policy strategies. Through his previous positions at the Senate Health, Education, Labor and Pensions (HELP) Committee and FDA’s Office of Chief Counsel, Wade provides unique insights to companies and trade associations regarding the evolving FDA regulatory landscape. He also serves as one of the leaders of Covington’s multidisciplinary Digital Health Initiative, which brings together the firm’s considerable resources across the broad array of legal, regulatory, commercial, and policy issues relating to the development and marketing of digital health technologies.
In his profile, Mr. Ackerman tells Daily Journal, “I love being able to practice in an area of law that is on the cutting edge of technology and developments in medicine. And to be able to do what I do here in California but still stay very closely connected to Washington and FDA issues both on the Hill and the Agency, I think I’m pretty lucky.”
Ms. Toro, a partner in our San Francisco office, advises both pharmaceutical and biotechnology companies regarding biologics, pharmaceuticals and devices, including in the digital health space. She works on all types of life sciences transactions, including major collaborations, licensing arrangements, clinical trial agreements, supply and distribution agreements, product development funding deals, and joint ventures and a variety of commercial agreements.
In her profile, Ms. Toro tells Daily Journal, “I’m always learning something because it’s a very dynamic industry as you can see with COVID-19 constantly changing and evolving. I didn’t come from a science background, but I enjoy learning about new technologies.”